WOOREE BIO (082850) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, WOOREE BIO (082850) reported revenue of 1.04 trillion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20251.04 trillion KRW952 million KRW-10.2 billion KRW[source]
20241.24 trillion KRW15.2 billion KRW8.2 billion KRW[source]
20231.26 trillion KRW26.0 billion KRW18.9 billion KRW[source]
20221.36 trillion KRW34.4 billion KRW25.1 billion KRW[source]
20211.54 trillion KRW42.8 billion KRW44.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202599.3 billion KRW11.1 billion KRW88.2 billion KRW[source]
2024106.9 billion KRW13.7 billion KRW93.2 billion KRW[source]
2023112.4 billion KRW18.4 billion KRW94.0 billion KRW[source]
2022116.5 billion KRW21.3 billion KRW95.3 billion KRW[source]
2021118.0 billion KRW24.7 billion KRW93.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice